Athira Pharma Inc’s recent filing unveils that its Chief Executive Officer Litton Mark James unloaded Company’s shares for reported $14026.0 on Jan 05 ’24. In the deal valued at $2.91 per share,4,820 shares were sold. As a result of this transaction, Litton Mark James now holds 144,397 shares worth roughly $0.31 million.
Then, Worthington Mark sold 2,412 shares, generating $7,019 in total proceeds. Upon selling the shares at $2.91, the General Counsel now owns 34,452 shares.
Before that, Lenington Rachel sold 2,412 shares. Athira Pharma Inc shares valued at $7,019 were divested by the Chief Operating Officer at a price of $2.91 per share. As a result of the transaction, Lenington Rachel now holds 13,395 shares, worth roughly $29201.100000000002.
JMP Securities upgraded its Athira Pharma Inc [ATHA] rating to a Mkt outperform from a a Mkt perform in a research note published recently. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in early July with a ‘”a Buy”‘ rating. Stifel also remained covering ATHA and has decreased its forecast on June 23, 2022 with a “Hold” recommendation from previously “Buy” rating. JMP Securities revised its rating on June 23, 2022. It rated ATHA as “a Mkt perform” which previously was an “a Mkt outperform”.
Price Performance Review of ATHA
On Tuesday, Athira Pharma Inc [NASDAQ:ATHA] saw its stock jump 10.66% to $2.18. Over the last five days, the stock has gained 10.66%. Athira Pharma Inc shares have fallen nearly -10.29% since the year began. Nevertheless, the stocks have fallen -26.35% over the past one year. While a 52-week high of $4.30 was reached on 02/21/24, a 52-week low of $1.33 was recorded on 04/25/24. SMA at 50 days reached $2.6200, while 200 days put it at $2.4200. A total of 0.2 million shares were traded, compared to the trading of 0.12 million shares in the previous session.
Levels Of Support And Resistance For ATHA Stock
The 24-hour chart illustrates a support level at 2.0200, which if violated will result in even more drops to 1.8500. On the upside, there is a resistance level at 2.2900. A further resistance level may holdings at 2.3900. The Relative Strength Index (RSI) on the 14-day chart is 48.22, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0200, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 14.93%. Stochastics %K at 41.14% indicates the stock is a holding.
